Skye Bioscience, Inc. Total Liabilities and Equity
Skye Bioscience, Inc. (SKYE) had Total Liabilities and Equity of $11.03 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $11.03M.
- 2026-03-31: Liabilities and Equity $19.42M.
- 2025-12-31: Liabilities and Equity $28.31M.
- 2025-09-30: Liabilities and Equity $41.32M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $11.03M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $19.42M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $28.31M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $41.32M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $52.16M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $64.79M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $72.76M 10-K · filed 2026-03-10 |
| 2024-09-30 | $81.54M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $87.26M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $94.84M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $11.94M 10-K · filed 2025-03-20 |
| 2023-09-30 | $15.60M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.24M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $4.59M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $9.11M 10-K · filed 2024-03-22 |
| 2022-09-30 | $2.87M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.97M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $7.21M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $9.86M 10-K · filed 2023-03-31 |
| 2021-09-30 | $11.69M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $5.49M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $5.40M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $2.67M 10-K · filed 2022-03-28 |
| 2020-09-30 | $4.35M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $227.21K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $672.98K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $2.00M 10-K · filed 2021-03-02 |
| 2019-09-30 | $1.73M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $3.08M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $4.72M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.96M 10-K · filed 2020-03-23 |
| 2018-09-30 | $1.17M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.04M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $3.16M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $557.22K 10-K · filed 2019-03-14 |
| 2017-09-30 | $343.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $484.05K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $617.39K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $323.36K 10-K · filed 2018-03-19 |
| 2016-09-30 | $692.13K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.08M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $2.35M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $3.51M 10-K · filed 2017-03-10 |
| 2015-09-30 | $4.54M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $820.79K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $468.73K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $348.35K 10-K · filed 2016-03-21 |
| 2014-09-30 | $1.13M 10-Q · filed 2014-11-14 |
| 2014-07-31 | $167.63K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $122.73K 10-Q · filed 2014-06-05 |
| 2014-01-31 | $140.84K 10-Q · filed 2014-03-17 |
| 2013-10-31 | $145.69K 10-Q · filed 2014-09-15 |
| 2013-07-31 | $128.99K 10-Q · filed 2013-09-16 |
| 2013-04-30 | $134.37K 10-Q · filed 2013-06-27 |
| 2012-10-31 | $42.88K 10-K · filed 2014-01-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |